NCT03711318View on ClinicalTrials.gov

Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals

PHASE3TerminatedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions

Heroin Dependence

Interventions

DRUG

Buprenorphine/naloxone

3 week treatment with buprenorphine/naloxone

Trial Locations (1)

10032

New York State Psychiatric Institute, New York

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Alkermes, Inc.

INDUSTRY

lead

New York State Psychiatric Institute

OTHER